INFINITY PHARMACEUTICALS, INC.·4

Jan 7, 4:05 PM ET

Agresta Samuel 4

4 · INFINITY PHARMACEUTICALS, INC. · Filed Jan 7, 2019

Insider Transaction Report

Form 4
Period: 2019-01-04
Agresta Samuel
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-04+62,59662,596 total
    Exercise: $1.24Exp: 2029-01-04Common Stock (62,596 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION